Yanghui Bi

1.3k total citations
25 papers, 352 citations indexed

About

Yanghui Bi is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Yanghui Bi has authored 25 papers receiving a total of 352 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 6 papers in Oncology and 5 papers in Cancer Research. Recurrent topics in Yanghui Bi's work include RNA modifications and cancer (7 papers), Cancer-related gene regulation (5 papers) and Epigenetics and DNA Methylation (4 papers). Yanghui Bi is often cited by papers focused on RNA modifications and cancer (7 papers), Cancer-related gene regulation (5 papers) and Epigenetics and DNA Methylation (4 papers). Yanghui Bi collaborates with scholars based in China, United States and Hong Kong. Yanghui Bi's co-authors include Xiao‐Jing Zhang, Yunxia Chen, Pengzhou Kong, Xiaoxia Tian, Caixia Cheng, Yongping Cui, Heyang Cui, Ruyi Shi, Xiaolong Cheng and Bei Sun and has published in prestigious journals such as Nutrients, European Journal of Pharmacology and Cancer Letters.

In The Last Decade

Yanghui Bi

24 papers receiving 351 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yanghui Bi China 12 205 87 74 43 37 25 352
Jinglue Song China 10 243 1.2× 95 1.1× 97 1.3× 54 1.3× 55 1.5× 16 411
Brittney S. Harrington United States 10 211 1.0× 87 1.0× 132 1.8× 35 0.8× 56 1.5× 19 393
Zhehui Zhu China 8 165 0.8× 54 0.6× 86 1.2× 54 1.3× 34 0.9× 18 332
Mohammed Benkheil Belgium 8 245 1.2× 80 0.9× 88 1.2× 65 1.5× 84 2.3× 8 443
Kailiang Zhao China 10 182 0.9× 73 0.8× 117 1.6× 41 1.0× 54 1.5× 38 354
Chantal Rodgarkia‐Dara Austria 9 249 1.2× 61 0.7× 78 1.1× 58 1.3× 19 0.5× 9 371
Л. В. Спирина Russia 12 238 1.2× 121 1.4× 81 1.1× 41 1.0× 56 1.5× 95 430
Zhangwei Tong China 9 235 1.1× 106 1.2× 90 1.2× 38 0.9× 41 1.1× 17 347
Weina Zhang China 11 173 0.8× 74 0.9× 68 0.9× 45 1.0× 37 1.0× 27 362

Countries citing papers authored by Yanghui Bi

Since Specialization
Citations

This map shows the geographic impact of Yanghui Bi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yanghui Bi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yanghui Bi more than expected).

Fields of papers citing papers by Yanghui Bi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yanghui Bi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yanghui Bi. The network helps show where Yanghui Bi may publish in the future.

Co-authorship network of co-authors of Yanghui Bi

This figure shows the co-authorship network connecting the top 25 collaborators of Yanghui Bi. A scholar is included among the top collaborators of Yanghui Bi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yanghui Bi. Yanghui Bi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xiao, Heng, Tong Zhou, Yanfang Yang, et al.. (2025). LncRNADANCR Promotes ESCC Progression and Function as ceRNA to Regulate DDIT3 Expression by Sponging microRNA‐3193. Cancer Science. 116(5). 1324–1338. 1 indexed citations
3.
Bi, Yanghui, Qing Li, Yan Li, et al.. (2024). Tumor-derived extracellular vesicle drug delivery system for chemo-photothermal-immune combination cancer treatment. iScience. 27(2). 108833–108833. 19 indexed citations
4.
Bi, Yanghui, Yanfang Yang, Yong Zhang, et al.. (2023). FBXW7 inhibits the progression of ESCC by directly inhibiting the stemness of tumor cells. Neoplasma. 70(6). 733–746. 2 indexed citations
5.
Zhang, Yunhua, Wenzhen Yin, Yuan Liang, et al.. (2023). Hepatic G Protein-Coupled Receptor 180 Deficiency Ameliorates High Fat Diet-Induced Lipid Accumulation via the Gi-PKA-SREBP Pathway. Nutrients. 15(8). 1838–1838. 4 indexed citations
6.
Bi, Yanghui, Ping Zhang, Yan Song, et al.. (2023). Rspo2-LGR4 exacerbates hepatocellular carcinoma progression via activation of Wnt/β-catenin signaling pathway. Gastroenterología y Hepatología. 47(4). 352–365. 1 indexed citations
7.
Xu, Xiaoqin, Xin Yang, Xue Liu, et al.. (2022). The Role of DBR1 as a Candidate Prognosis Biomarker in Esophageal Squamous Cell Carcinoma. Technology in Cancer Research & Treatment. 21. 2213824993–2213824993. 3 indexed citations
8.
Li, Hongyi, Shaojie Wang, Fang Wang, et al.. (2021). CDCA7 Facilitates Tumor Progression by Directly Regulating CCNA2 Expression in Esophageal Squamous Cell Carcinoma. Frontiers in Oncology. 11. 734655–734655. 14 indexed citations
9.
Kong, Pengzhou, Enwei Xu, Yanghui Bi, et al.. (2020). Novel ESCC-related gene ZNF750 as potential Prognostic biomarker and inhibits Epithelial-Mesenchymal Transition through directly depressing SNAI1 promoter in ESCC. Theranostics. 10(4). 1798–1813. 28 indexed citations
10.
Zhang, Ling, Xiaojuan Zhang, Haitao Zhang, et al.. (2020). Knockdown of SF3B1 inhibits cell proliferation, invasion and migration triggering apoptosis in breast cancer via aberrant splicing. Breast Cancer. 27(3). 464–476. 11 indexed citations
11.
Zhang, Yunhua, et al.. (2020). Expression and purification of asprosin in Pichia pastoris and investigation of its increase glucose uptake activity in skeletal muscle through activation of AMPK. Enzyme and Microbial Technology. 144. 109737–109737. 19 indexed citations
12.
Zhang, Ling, Xiaojuan Zhang, Min Guo, et al.. (2020). TSTA3 facilitates esophageal squamous cell carcinoma progression through regulating fucosylation of LAMP2 and ERBB2. Theranostics. 10(24). 11339–11358. 19 indexed citations
13.
Yang, Bin, Huijuan Liu, Yanghui Bi, et al.. (2020). MYH9 promotes cell metastasis via inducing Angiogenesis and Epithelial Mesenchymal Transition in Esophageal Squamous Cell Carcinoma. International Journal of Medical Sciences. 17(13). 2013–2023. 27 indexed citations
14.
15.
Hou, Guofang, et al.. (2018). Recent advances in research on aspartate β-hydroxylase (ASPH) in pancreatic cancer: A brief update. Bosnian Journal of Basic Medical Sciences. 18(4). 297–304. 32 indexed citations
16.
Zhang, Huiying, et al.. (2016). [Dynamic changes of TGF-α and TGF-β1 in rats with liver cirrhosis induced by multiple pathogenic factors].. PubMed. 32(1). 65–8. 1 indexed citations
17.
Shi, Ruyi, Heyang Cui, Yanghui Bi, et al.. (2015). Artesunate altered cellular mechanical properties leading to deregulation of cell proliferation and migration in esophageal squamous cell carcinoma. Oncology Letters. 9(5). 2249–2255. 20 indexed citations
19.
Liu, Yingwen, Yanghui Bi, Lin Jia, et al.. (2014). Tag SNPs of CFI contributed to the susceptibility for non-small cell lung cancer in Chinese population. Tumor Biology. 36(3). 1955–1962. 2 indexed citations
20.
Zhang, Ling, Ruyi Shi, Caixia Cheng, et al.. (2013). Oncogenic B-RafV600E abrogates the AKT/B-Raf/Mps1 interaction in melanoma cells. Cancer Letters. 337(1). 125–132. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026